New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
ANTITACHYCARDIA PACING AND LOW-ENERGY CARDIOVERSION FAR VENTRICULAR-TACHYCARDIA TERMINATION - A CLINICAL PERSPECTIVE
ANTITACHYCARDIA PACING AND LOW-ENERGY CARDIOVERSION FAR VENTRICULAR-TACHYCARDIA TERMINATION - A CLINICAL PERSPECTIVE Symposium on Electrical Device Therapy for Cardiac Arrhythmias: New Concepts, Problems, and Alternatives Estes, N. A., Haugh, C. J., Wang, P. J., Manolis, A. S. MOSBY-YEAR BOOK INC. 1994: 1038–46Abstract
When incorporated into tiered therapy implantable cardioverter defibrillators (ICDs), antitachycardia pacing (ATP) techniques have proved useful for termination of sustained monomorphic ventricular tachycardias (VT) and have the advantages of rapid delivery, absence of patient discomfort, and minimal battery drain. The efficacy of low-energy cardioversion (LEC) is similar to that of pacing techniques for VT termination, but LEC has the disadvantages of patient discomfort, atrial proarrhythmia, and greater battery drain compared with ATP. Acceleration of VT occurs with similar frequency with each technique. Neither technique should be used without back-up defibrillation capability in an ICD. VT termination algorithms are currently empiric and require repetitive arrhythmia induction and trials of ATP or LEC. Future studies of the risk and benefits of each technique are likely to define optimal programming strategies in tiered therapy ICDs.
View details for Web of Science ID A1994NF85500011
View details for PubMedID 8160578